Overall, the results of the study of their antiparasitic effects against L. amazonensis, as well as the binding ability toward HSA revealed the chalcone-thiosemicarbazone class as a novel prototype for drug development against leishmaniasis. The gene discussed is ALB; the disease is leishmaniasis.